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Inhibition of the insulin/insulin-like growth factor signalling pathway increases lifespan and protects against
neurodegeneration in model organisms, and has been considered as a potential therapeutic target. This path-
way is upstream of mTORC1, a negative regulator of autophagy. Thus, we expected autophagy to be activated
by insulin-like growth factor-1 (IGF-1) inhibition, which could account for many of its beneficial effects.
Paradoxically, we found that IGF-1 inhibition attenuates autophagosome formation. The reduced amount of
autophagosomes present in IGF-1R depleted cells can be, at least in part, explained by a reduced formation of
autophagosomal precursors at the plasma membrane. In particular, IGF-1R depletion inhibits mTORC2,
which, in turn, reduces the activity of protein kinase C (PKCa/b). This perturbs the actin cytoskeleton dynamics
anddecreases the rateofclathrin-dependent endocytosis,which impactsautophagosomeprecursor formation.
Finally, with important implications for human diseases, we demonstrate that pharmacological inhibition of the
IGF-1R signalling cascade reduces autophagy also in zebrafish and mice models. The novel link we describe
here has important consequences for the interpretation of genetic experiments in mammalian systems and
forevaluating thepotentialof targeting the IGF-1Rreceptorormodulating itssignalling through thedownstream
pathway for therapeutic purposes under clinically relevant conditions, such as neurodegenerative diseases,
where autophagy stimulation is considered beneficial.
INTRODUCTION
The insulin-like growth factor (IGF-1) binds to extracellular
insulin-like growth factor receptors, such as the insulin-like
growth factor-1 receptor (IGF-1R), resulting in their activation
and phosphorylation. The tyrosine kinase activities of these
receptors phosphorylate signalling molecules, including the
insulin receptor substrate (IRS) protein family.Oncephosphory-
lated, the IRS proteins act as molecular adaptors to facilitate
downstream signalling pathways via AKT, which serves as a
major effector. Inhibition of insulin/IGF-1 signalling is consid-
ered an exciting therapeutic target, as this modulation increases
lifespan inworms, flies andmice, and also protectsmodel organ-
isms from neurodegenerative insults (1–4).
Autophagy, a critical cytoprotective pathway, involves the
formation of double-membrane autophagosomes that capture
portions of cytoplasm before fusing with lysosomes where
their contents are ultimately degraded (5).Autophagy is a critical
pathway that regulates the accumulation of such cytoplasmic
aggregate-prone proteins, such as mutant huntingtin, associated
with neurodegenerative diseases. Autophagy-inducing drugs
and genes can alleviate the toxicity of mutant huntingtin and
related proteins in cell and animalmodels of disease (6). Further-
more, autophagy up-regulation in model organisms increases
longevity (7). In mammalian cells, autophagosomes are
formed from precursor membrane structures that include a
complex of the autophagic proteins Atg5, Atg12 and Atg16L1.
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These precursors have been proposed to originate from a variety
of sources, including the plasmamembrane, the endoplasmic re-
ticulum and mitochondria (8). These sources may not be mutu-
ally exclusive; although the endoplasmic reticulum and
mitochondria appear only to be relevant under starvation condi-
tions when autophagy is induced, while the plasma membrane
contributes to autophagosome precursors under both induced
and basal autophagy conditions (9). The plasma membrane is
recruited to autophagosome precursors as a result of Atg16L1
binding to clathrin-coated pits (9). After endocytosis, which is
required for autophagosome formation, the autophagosome pre-
cursors undergo homotypic fusion, which increases their size.
This appears to be a prerequisite for recruiting the protein
LC3-II, and the transition to a phagophore, which starts to
engulf cytoplasmic contents before its edges fuse to become a
completed autophagosome (10). At this stage, the
Atg5-12-16L1 complex dissociates from the autophagosome.
LC3-II is the only known protein that specifically associates
with autophagosomes and not with other vesicular structures
(11), and a standard way of measuring autophagosome number
is by assaying LC3-II levels (as a function of actin/tubulin) or
by counting the number of LC3-positive vesicles (11).
It has been reported that both IGF-1 inhibition and autophagy
activation have beneficial effects on lifespan (1–4) and neurode-
generative insults (6,7). Since IGF-1 has been reported to block
autophagy throughAKT inhibition, which would be expected to
occur via AKT activation of the direct autophagy inhibitor rapa-
mycin complex 1 (mTORC1) (12,13), we anticipated chronic
IGF-1 pathway inhibition to induce autophagy, which could
account for many of its beneficial properties.
RESULTS
IGF-1R depletion decreases autophagy
In order to mimic the potential therapeutic strategies of chronic
inhibition of IGF-1 signalling based on the in vivo knockout lit-
erature (1–4), we initially investigated the effects of knocking
down IGF-1R in cell culture systems. Contrary to expectations,
IGF-1R knockdown decreased LC3-II levels in HeLa cells
grown in a normal medium, as well as in cells treated with satur-
ating levels of bafilomycinA1,whichblocksLC3-II degradation,
thereby allowing one to infer LC3-II formation rates (11), sug-
gesting that LC3-II/autophagosome formation was reduced
(Fig. 1A and B). Furthermore, IGF-1R depletion also decreased
autophagosome formation in mouse embryonic fibroblasts
(MEFs)derived fromIGF-1Rhemizygousmice (Supplementary
Material, Fig. S1A and B).
The endogenous autophagy substrate p62/sequestosome 1
(14) was increased in cells where IGF-1R was knocked down
(Fig. 1C). Interestingly, the accumulation of p62 was autophagy
dependent, since this effectwas abrogated in thepresenceofbafi-
lomycin A1 (Fig. 1A–C). Another well-known and character-
ized autophagy substrate is mutant huntingtin with an
expanded polyQ tract, associated with Huntington’s disease.
The percentage of cells with mutant huntingtin aggregates
increases linearly as a function of its expression and is increased
by autophagy inhibitors (15). Such an effect also occurred upon
IGF-1R knockdown (Fig. 1D).
In order to corroborate the effects of IGF-1R inhibition on
autophagy, we used a monoclonal antibody (MAB391) that
induces time-dependent degradation of the human IGF-1R re-
ceptor (16). LC3-II levels in the presence of bafilomycin A1
were significantly reduced after 8 h treatment with this antibody
and to a greater extent at 24 h (Fig. 1E and F), as were the
numbers of GFP-LC3 vesicles (Supplementary Material,
Fig. S1C). Note worthily, the reduction in autophagosome for-
mation observed in these experiments is as large as we see
when we knockdown key autophagy genes (10). Likewise,
MAB391-driven IGF-1R depletion enhanced the accumulation
of GFP-Q74 (Supplementary Material, Fig. S1D). Interestingly,
we also found that a long-term serum deprivation (8 and 24 h)
also reduced autophagosome formation (Supplementary Mater-
ial, Fig. S1EandF), even though it has beenpreviously described
how, under certain metabolic conditions, a short-term serum de-
privation can induce autophagy (17,18). This might be compat-
ible with the IGF-1R depletion, since both the strategies would
inhibit growth factor-mediated signalling.
We then tested whether medium-term IGF-1R stimulation
would modulate LC3-II accumulation in the presence of bafilo-
mycinA1 (11),when IGF-1was addedback to cells that had been
serum starved for the previous 24 h (since serum starvation
depletes cells of growth factors). Importantly, this strategy
enables kinetic experiments that are not possiblewith the knock-
down and antibody approaches we used above. While 8 h of
IGF-1 supplementation had no clear effects on autophagy
(Fig. 1G–I), prolonged (24 h) IGF-1 stimulation resulted in
a dramatic increase in LC3-II formation in serum-starved
cells, much above the levels observed in serum-starved,
non-IGF-1-treated cells (Fig. 1H and I). This effect was compat-
ible with the decreased autophagy we observed upon long-term
IGF-1R inhibition (Supplementary Material, Fig. S1E and F).
Moreover, we also reproduced this phenomenon in mouse
primary cortical neurons (Supplementary Material, Fig. S1G
and H).
Signalling consequences of IGF-1R depletion
We expected IGF-1R inhibition to reduce downstream mTOR
activity. mTOR activity resides in two kinase complexes, the
mTORC1andmTORC2.ThemTORC1complex that negatively
regulates autophagy also phosphorylates protein p70S6Kinase,
and its phosphorylation iswidely used to infermTORC1 activity
(19). Surprisingly, IGF-1R siRNA resulted in no obvious effects
oneitherAKTphosphorylation atT308,which correlateswith the
downstream mTOR activation (20), FOXO-3A phosphoryl-
ation, which has been reported to transcriptionally modulate
autophagy (21), or the phosphorylation of p70S6 K, a direct sub-
strate of themTORC1 complex (Fig. 1J and SupplementaryMa-
terial, Fig. S1I). As we observed with IGF-1R siRNA,MAB391
did not decrease p70S6 K phosphorylation, and had no discern-
ible effect on AKT T308 phosphorylation (Fig. 1K and Supple-
mentary Material, Fig. S1J). In view of the intimate connection
between lysosomes and mTOR signalling (17,22), we also
assessed whether lysosomal positioning might be altered in
IGF-1R depleted cells, but without observing any significant
variation in the intracellular localization of lysosomes (Fig. 1L
and M). Furthermore, IGF-1R inhibition did not influence
either lysosomal pH (Fig. 1N and O) or the degradation activity
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Figure 1. IGF1-R inhibition decreases autophagy. (A–C) HeLa cellswere transfected for 72 hwith 50 nM of either control or anti-IGF-1R siRNA. For the assessment
of autophagy by LC3-II levels, bafilomycin A1 was added to the cells in the last 4 h before harvesting. The western blot panels are representative of at least three
independent experiments performed in triplicate. The graphs in (B) and (C) report the IGF-1R, LC3-II and p62 levels relative to actin. TheP-values were determined
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of the lysosomal compartment (Supplementary Material,
Fig. S1K and L).
Sustained IGF-1 signalling rescues autophagy inhibition
caused by long-term serum deprivation
The effects of IGF-1R signalling inhibition over 24 h (described
in Fig. 1J and K and SupplementaryMaterial, Fig. S1I and J) are
different fromwhatwe expected to observe in short-term experi-
ments. This suggested a feedback loop,whichwe investigatedby
adding back IGF-1 to cells that had been serum starved for 24 h.
Serum starvation decreased p70S6 K phosphorylation almost as
severely as the mTORC1-specific inhibitor rapamycin (Fig. 2A
andB; compareCtrl versusRap andCtrl versus -FBS).However,
when we added back IGF-1 to these serum-deprived cells, we
observed a surprising result. While, as we would have expected,
IGF-1 treatment for 60–120 min resulted in a prompt rise in the
phosphorylation of both AKT and p70S6 K, both AKT and
mTOR activity (as determined by p70S6 K phosphorylation)
decreased dramatically after 24 h of IGF-1 treatment (Fig. 2A
and B; please, compare FBS versus 1–8 h and FBS versus
24 h). However, there appeared to be slightlymoremTORactiv-
ity andAKTphosphorylation in cells treatedwith IGF-1 for 24 h
after 24 h starvation, compared with starved cells (Fig. 2A and
B). These effects were not associated with caspase-3 activation
(Fig. 2A).
Again, similar phenomena were observed in primary cortical
neurons (Fig. 2CandD). Inparticular,whenwe removed theB27
supplement (which contains insulin) for 24 h, we observed
reduced p70S6 K phosphorylation (Fig. 2C and D), such as in
HeLa cells (Fig. 2A and B). When we added back IGF-1 to
B27-depleted neurons, we saw a dramatic increase inmTOR ac-
tivity up to 8 h, which then declined after 24 h (Fig. 2C and D),
again mimicking the experiment performed in HeLa cells
(Fig. 2A and B).
Importantly, under our experimental conditions these feed-
back effects of the mTOR activity were largely autophagy inde-
pendent (23). The increases and then decreases in p70S6 K
phosphorylation were observed in serum-starved wild-type
and Atg5 null, autophagy-deficient MEFs exposed to IGF-1 for
different periods, even though the initial increase in phosphoryl-
ation appeared slightly blunted in the Atg5 null MEFs (Fig. 2E),
as well as in HeLa cells exposed to either control or ATG16L1
siRNA, which also knocks down a key autophagy gene
(Fig. 2F and G). Therefore, the effects of IGF-1R inhibition on
downstream signalling were unexpected, but could be explained
by compensatory feedback loops involving some critical down-
stream effectors (IRS-1/-2 and AKT) (please, for further expla-
nations and discussion refer to Supplementary results, Fig. S2
and related references contained in the Supplementary Material
section).
IGF-1R inhibition decreases autophagosome formation by
reducing endocytosis
Since the signalling data did not provide a simple explanation for
the unexpected effects of IGF-1R inhibition on autophagy, we
considered alternative mechanisms. Despite consistently redu-
cing LC3-II levels (Fig. 3A) and the numbers of LC3 vesicles
(Supplementary Material, Fig. S3A–C), MAB391 did not
affect the levels of the autophagy-related proteins Atg16L1,
Atg4B, Beclin-1, Ulk-1 (6), the levels of the Atg5-12 conjugate
that regulate LC3-II formation (24), or the levels of phosphory-
lated Bcl-2 (25), and p53 that regulate autophagy (26) (Fig. 3A
and B). In addition, we observed no change either in transcrip-
tional activation of the FOXO-3A responsive element or in the
LC3, Atg16L1, Atg4B, Ulk-1 and Beclin-1 promoters upon
IGF-1R depletion (Fig. 3C).
Interestingly, although IGF-1R depletion did not alter
Atg16L1 protein levels (Fig. 3A), it decreased the numbers
of GFP-Atg16L1-positive vesicles in cells after MAB391-
mediated depletion of the IGF-1R receptor (Fig. 3D–F). We
used GFP-Atg16L1 here, since one cannot detect quantifiable
numbers of these vesicles using antibodies to endogenous
protein under basal conditions; while this can be done by indu-
cing autophagy using full amino acid starvation, this perturb-
ation would not be feasible for an experiment aiming to test
the effects of IGF-1R depletion. However, we have extensively
validated the use of this approach (9,10). Interestingly, the inter-
action between clathrin heavy chain and endogenous Atg16L1
protein was reduced in cells depleted of the IGF1-R receptor
(Fig. 3G and H). Thus, the lower amount of LC3-II (i.e. mature
autophagosomes) present in IGF-1R depleted cells can be, at
least in part, explained by a reduced formation of autophagoso-
mal precursors at the plasma membrane. We tested whether this
phenotype was associated with a concomitant reduction in the
by two-tailedStudent’s t-test (B:n ¼ 3;CTRLversus 24 h IGF-1R; ∗P ¼ 0.0173; ∗∗P ¼ 0.0048;C:n ¼ 3;CTRLversus IGF-1R; ∗∗P ¼ 0.0355). (D)HeLacellswere
transfected for 96 h with 50 nM of either control or anti-IGF-1R siRNA. In the last 48 h, cells were re-transfected with the same siRNAmixture plus the GFP-HD74
vector. TheP-value for assessing theEGFP-HDQ74 aggregationwas determined usingStudent’s t-test (n ¼ 3;CTRLversus IGF-1R siRNA, ∗P ¼ 0.0283). (E andF)
IGF1-R depletion time-dependently decreases autophagy.HeLa cellswere treated for the indicated time pointswith theMAB391 neutralizing antibody. Bafilomycin
A1was added to the cells in the last 4 h. The graph reports IGF-1RandLC3-II levels relative to actin. TheP-valueswere determinedbyFactorialAnova (n ¼ 3;CTRL
versus24 hMAB391, ∗P ¼ 0.0192and ∗∗P ¼ 0.0049). (Gand I)HeLacellswere serumstarved for24 hand then stimulatedornot (vhc, vehicle) by IGF-1R3 foreither
8 (G)or 24 h (H).BafilomycinA1was added to the cells in the last 4 h before harvesting.Thegraph reportsLC3-II levels relative to actin test (I:n ¼ 3;CTRLversus no
fbs ∗P ¼ 0.0341 and ∗∗P ¼ 0.0026; no fbs versus 24 h IGF-1 ∗∗P ¼ 0.0059 and ∗∗P ¼ 0.0085). (J) HeLa cells were transfected as reported in (A). The western blot
panels show the effect of IGF-1R knock-down on the IGF-1/AKT/mTOR pathway. (K) HeLa cells were treated for 24 h withMAB391, and then samples were ana-
lysed bywestern blot to check levels of the indicated proteins (see also SupplementaryMaterial, Fig. S1I and J). In all panels, error bars represent standard deviations.
(L andM) HeLa cells seeded on glass coverslipswere treated or not with theMAB391neutralizing antibody.After 24 h, the cells were fixed, permeabilized inmetha-
nol, stainedwithanti-LAMP1specificantibodyandfinallyanalysedbyconfocalmicroscope.Twohundredcells for eachexperimental conditionwereanalysedusinga
fluorescencemicroscope, and the number of cells presenting a perinuclear versus peripheral lysosomal distributionwas scored.TheP-value for assessing the variation
in lysosomal positioningwas determined using Student’s t-test (n ¼ 3; ns, nonsignificant). (N andO) IGF-1R depletion does not affect acidification of the lysosomal
compartment. HeLa cells were seeded onMatTek Petri dish and treated or not withMAB391. After 24 h, the cells were loadedwith the LysoSensor as detailed in the
Methods section and then analysed by confocal live imaging. The graph shows themean valuewith standard deviation of the yellow/blue ratio obtained from 10 con-
focal fields for each experimental condition, from three independent experiments. Bafilomycin A1 was used as a standard positive control (O: n ¼ 3; CTRL versus
MAB391: ns, nonsignificant; CTRL versus BafA1, ∗∗∗P ¼ 0.00026).
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Figure 2. Sustained IGF-1 signalling rescues autophagy inhibition by long-term serum deprivation. (A and B) HeLa cells were serum starved for 24 h and then sti-
mulated by 200 ng/ml of the IGF-1R3 analogue for the indicated time points.Cells treatedwith rapamycin (200 nM for 24 h)were included as a positive control for the
mTOR inhibition. Thewestern blot panels reporting the effect of serum deprivation and IGF-1 add-back protocol on phospho/total AKT, phospho/total p70S6Kinase
levels and caspase-3 cleavage are representative of at least three independent experiments performed in triplicate. The P-values of the densitometric analysis were
determinedbyFactorialAnova (n ¼ 3; ∗P, 0.05; ∗∗∗P , 0.001; ns ¼ nonsignificant). Please note that the serumdeprivation (orB27, in the caseof primaryneuronal
cultures) approach we have used in the experiments described in this figure as well as in Supplementary Material, Figure S2, should not be considered as a standard
starvation protocol (such as incubationwithHBSSor EBSSmedium), as themedia contains L-glutamine,whichwould promote autophagy. (C andD)Mouse primary
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rate of endocytosis (27). Compared to control, cells treated with
theMAB391 antibodyhad significantly decreased transferrin re-
ceptor internalization (Fig. 3I), an assay used to measure the dy-
namics of clathrin-dependent endocytosis (28). Likewise, we
showed a time-dependent reduction in the rate of transferrin re-
ceptor internalization in cells treated with the PI3-kinase inhibi-
tor LY-294002, suggesting that the observed effect might be
dependent on the activity of the Class I PI(3)K (Fig. 3J). We
then asked whether IGF-1R agonism might have an effect on
endocytosis. Surprisingly, and consistent with the effect of
short- and long-term IGF-1 stimulation on autophagy (Fig. 2
and Supplementary Material, Fig. S2), we observed reduced
endocytosis in serum-starved cells (Supplementary Material,
Fig. S3D; compare CTRL versus NO FBS). Moreover, a pro-
longed (24 h) but not short-term (2 h) IGF-1 stimulation of pre-
viously serum-starved cells enabled recovery of endocytosis
(Supplementary Material, Fig. S3D; compare NO FBS with 2
and 24 h IGF-1), consistent with this paradigm being able to
recover (upon long-term stimulation) the autophagosome for-
mation (see also Fig. 1G–I and Supplementary Material,
Fig. S1G and H). Thus, IGF-1R depletion inhibits endocytosis
and the interaction of Atg16L1 with clathrin, which would, in
turn, decrease early autophagosome precursor formation at the
plasma membrane (9).
IGF-1R modulates mTORC2-PKCa/b -actin cascade
to regulate autophagy
In order to understand how IGF-1R signalling could modulate
autophagy via endocytosis, we considered the mTORC2
pathway, a known downstream effector of IGF-1R, which has
not been linked clearly with autophagy (please, see supporting
note and related references). As expected, IGF-1R depletion
decreased the activity of this complex, as it reduced the down-
stream phosphorylation at the mTORC2-dependent site (serine
473) on AKT (Fig. 4A). The mTORC2 complex is known to
regulate actin dynamics via protein kinase C a/b (PKCa/b)
(29–31) and MAB391 treatment resulted in decreased PKCa/
b activity (Fig. 4B), as well as obviously altered actin cytoskel-
eton (Fig. 4C). Notably, we observed a striking correlation
between actin cytoskeleton morphology and the number of
Atg16L1-positive vesicles (Fig. 4D). In particular, the actin
cytoskeleton derangement consequent to MAB391 treatment
was associated with decreased numbers of Atg16L1 autophago-
some precursors (Fig. 4E and F). By treating cells with the actin
polymerization inhibitor latrunculin A, we confirmed that the
actin cytoskeleton is required for effective endocytosis (32)
(Supplementary Material, Fig. S4A) and, consistent with
recent observations (33), showed that it is involved in early
events of autophagosome formation (Fig. S4B–E). We
therefore tested this potential mechanism in greater depth.
Genetic knockdown of Rictor, a critical component of the
rapamycin-insensitive mTORC2 (but not mTORC1) complex,
reduced PKCa/b \xEF\x80phosphorylation (Fig. 5A and B),
and both Rictor and PKCa knockdown severely disrupted the
actin cytoskeleton (Fig. 5C), reduced endocytosis (Fig. 5D),
lowered thenumbers ofAtg16L1vesicles (Fig. 5E) and, as a con-
sequence, decreased autophagosome formation (Fig. 5F–H).
Notably, Rictor selective knockdown had no effects on
mTORC1 signalling (Supplementary Material, Fig. S5A and
B). Moreover, long-term treatment (8–24 h) with Torin-1, a
novel mTORC1 and mTORC2 catalytic inhibitor (34),
decreased autophagosome formation, while inhibiting (differ-
ently from MAB391) mTORC1 activity (Supplementary
Material, Fig. S5C–E). All together, these data show how
mTORC2 and PKCa/b inhibition, and disruption of the actin
cytoskeleton are sufficient to impair autophagosome precursor
biogenesis, and thus can account, at least in part, for the
autophagy-inhibitory effects of reducing IGF-1R signalling.
IGF-1R inhibition attenuates autophagy in vivo
In order to assess whether our cell-based data were relevant in
vivo, where one might envisage IGF-1R inhibition to be
employed as a therapeutic strategy, we studied the effect of
picropodophyllin (PPP), a selective IGF-1R inhibitor (Supple-
mentary Material, Fig. S6) (35,36). Among the various
IGF-1R chemical inhibitors that are currently available, we
decided to focus on the cyclolignans family member PPP,
because of previous reports showing specific inhibition of
IGF-1R tyrosine phosphorylation and activity, without effects
on other relevant tyrosine kinase receptors (35). In particular,
cyclolignans can specifically and efficiently reduce the
auto-phosphorylation, activity andhencedownstreamsignalling
of IGF-1R in different cell lines; furthermore, PPP has been
shown to be virtually non-toxic in animal models (35,36). Con-
sistent with IGF-1R knockdown and MAB391 treatment, non-
toxic doses of PPP (Fig. 6A and Supplementary Material,
Fig. S6) attenuated mTORC2 activity (i.e. AKT-S473 phosphor-
ylation) and the PKCa/b phosphorylation (Fig. 6B and C), per-
turbed the actin cytoskeleton morphology, reduced endocytosis
and Atg16L1 vesicle numbers (Fig. 6D–F) and, as a conse-
quence, inhibited autophagosome formation (Fig. 6G). The
slight decrease of total PKCa inn PPP-treated cells might be
due to a concomitant enhanced degradation (37,38). Consistent
with these data, PPP treatment increased the intracellular levels
of selective autophagy substrates, such as p62 protein (Fig. 6H)
andmutantA53Ta-synuclein (Fig. 6I), aswell as the proportion
of cells with GFP-Q74 mutant huntingtin aggregates (Fig. 6J).
Interestingly, sincePPPaffects IGF-1Ractivity (i.e. phosphoryl-
ation of downstream modules) but not its own levels (Fig. 6B),
such experimental approach allow us to dissociate any effect
observed upon inhibition of IGF-1R signalling from those
that might rather depend on the IGF-1R receptor degradation.
cortical neuronswere deprived ofB27 supplement for 24 h and then stimulated by 200 ng/ml of IGF-1R3 for the indicated time points. Thewestern blot panels report-
ing theeffect ofB27deprivation/IGF-1add-backonphospho/total p70S6 Krelative levels are representativeof three independent experimentsperformed in triplicate.
TheP-valuesof thedensitometric analysisweredeterminedbyFactorialAnova (n ¼ 3; ∗∗∗P , 0.001). (E)ATG5+/+ andATG52/2MEFcellswere serumstarvedfor
24 h and then stimulated by IGF-1R3 for the indicated time points. Thewestern blot panels are representative of at least three independent experiments. (F)HeLa cells
were transfected for 96 h with either control or anti-ATG16L1 siRNA. The western blot panels report the effect of ATG16L1 knockdown on LC3-II levels. (G)
Control- or Atg16L1-siRNA transfected HeLa cells were serum starved for 24 h and then stimulated by IGF-1 R3 for the indicated time points. The western blot
panels reporting the effect of serum deprivation/IGF-1 add-back protocol on the phospho/total p70S6Kinase levels are representative of three independent experi-
ments. In all the panels, error bars represent standard deviations.
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Figure 3. IGF1-R inhibition decreases autophagosome precursor formation by reducing clathrin-dependent endocytosis. (A and B) HeLa cells were treated for 24 h
with theMAB391antibody toevaluate the effect of the IGF-1Rdepletionon the levels of the indicatedautophagy-relatedproteins.Thewesternblots are representative
of experiments performed in triplicate. (C)HeLacellswere transfectedwith0.5 mgfirefly luciferase reporterplasmidscontaining theFOXO-3Aresponsiveelement or
the indicatedAtggenepromotersplus0.05 mgof theRenilla luciferase reportercontrolplasmid.After24 h, thecellswere treated for a further24 hwithMAB391.RLU
values are reported as the average and standard deviations of at least three independent experiments carried out in triplicate. Statistical analysis was performed using
Student’s t test (n ¼ 3; CTRL versus 24 hMAB391, FOXO-3A: P ¼ 0.2825, LC3: P ¼ 0.1707, ATG16L1:P ¼ 0.2268, ATG4B:P ¼ 0.0672, ULK-1:P ¼ 0.0768,
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Nonetheless, the PPP data are entirely consistent with what
we have reported above with either genetic knockdown of the
receptor or MAB391 treatments in terms of modulation of
mTORC2-related signalling and autophagy.
We initially assessed the effects of PPP in vivo in a zebrafish
model, where we have previously optimised the use of NH4Cl
as an autophagosome degradation blocker analogous to bafilo-
mycinA1 (39). PPP decreased autophagosome formation in zeb-
rafish larvae (Fig. 7A and B). Consistent with these data, PPP
treatment increased the number of aggregates ofmutant hunting-
tin expressed in the zebrafish rodphotoreceptors (Fig. 7CandD),
in a manner similar to what we previously observed with other
autophagy inhibitors (39,40). This also contrasts with the reduc-
tion in aggregate numbers in this model seen with autophagy
inducers, as we have observed previously (41), and as shown
herewith clonidine (Fig. 7C andD). Inmice, intra-peritoneal ad-
ministration of PPP effectively decreasedAKT phosphorylation
(S473) as well as PKCa/b phosphorylation, and reduced LC3-II
levels inmouse liver (Fig. 7E) andmuscle (Fig. 7F). Overall, the
effects exerted by PPP in vivo appear to be biologically signifi-
cant—for instance, in the zebrafish the huntingtin aggregate
counts increased by 30% (Fig. 7D) whereas in the mouse
muscle, there appeared to be a reduction of LC3 by 50%
(Fig. 7F). Hence, IGF-1R antagonism can effectively down
modulate the activity of the autophagic pathway in vivo.
DISCUSSION
The IGF-1R pathway has received extensive attention as its in-
hibition increases lifespan and ameliorates neurodegenerative
diseases in a range of model organisms (1–4). Furthermore,
the potential druggability of the receptor suggests that it may
be suitable for therapeutic targeting. Nonetheless, our data
suggest that serious caution is warranted with this approach.
IGF-1R inhibition decreases mTORC2, which, in turn, reduces
the activity of PKCa/b. This perturbs the actin cytoskeleton
and decreases the rate of endocytosis, which impacts autophago-
some precursor formation (summarized in Fig. 7G). Thus, con-
trary to expectations, IGF-1R inhibition has liabilities with
regard to autophagy. These data are consistent with a study
from Yamamoto et al., who showed that IRS2 positively regu-
lates mutant huntingtin clearance in an autophagy-dependent
manner, although this study did not make connections with
IGF-1R or mTORC2 signalling (42). Our findings have import-
ant consequences for the interpretation of genetic experiments in
mammalian systems and for evaluating the potential of targeting
the receptor and/or modulating signalling through the
downstream pathway for therapeutic purposes. For instance,
this additional mechanism would likely have impact on the
overall efficacy of IGF-1R down-modulationwith respect to neu-
rodegenerative diseases, where autophagy is beneficial
(7,13,15,41–43).Thismayevenbe relevant in termsof longevity,
since IGF-1R signalling inhibition does not appear to have clear
effects on lifespan in male mice (44), leading these authors to
suggest that the effects of inhibiting this pathway in mammals
may not be as straightforward as has been predicted by inverte-
brate studies (44). One may be able to bypass this additional
effect by targeting downstream effectors of the IGF-1R
pathway, although these should also be tested for unforeseen
side effects. Moreover, from a pharmacological point of view,
such modules could result more challenging to be targeted than
the receptor itself. Indeed, it is tempting to speculate that one
may be able to achieve synergistic benefits by inhibiting the key
effectors of the IGF-1R pathway, alongside pharmacological
stimulation of the autophagic pathway. Finally, our data also
suggest that there may be benefits in using dual mTORC1/2 cata-
lytic inhibitors if administered over longer periods, as these may
result in inhibiting autophagy, which may decrease viability of
at least some types of cancers (43,45,46).
MATERIALS ANDMETHODS
Antibodies
The following antibodies have been used in this work: anti-LC3
(Novus Biological); anti-human IGF-1R neutralizing antibody
(MAB391, R&D Systems); mouse monoclonal anti-LC3
(Nanotools); mouse monoclonal anti-LAMP1 (clone H4A3,
obtained from Developmental Studies Hybridoma Bank,
University of Iowa); anti-IGF-1R, anti-IRS-1, anti-IRS-2,
anti-bcl2, anti-p53, anti-phospho(T308)-AKT (SantaCruz)
anti-Beclin-1, anti-phospho-Bcl2, anti-Ulk1, anti-caspase-3,
anti-phospho(T389) and total-p70S6kinase, anti-phospho
(S473) and total-AKT, anti-phospho-PKC(a/b) and
total-PKCa; anti-Rictor, anti-phospho- and total-FOXO3A
(Cell Signal); anti-human sestrin-1 antibody (Abnova);
anti-clathrin heavy chain and anti-p62 (BD Bioscience); anti-
Atg16L1 (MBL); anti-Atg5 and anti-actin (Sigma); anti-Atg4B
(AbCam); anti-HA antibody (Covance); anti-mouse and anti-
rabbit HRP-conjugated secondary antibodies (GE Healthcare),
AlexaFluor594- and AlexaFluor488-conjugated goat anti-
mouse; AlexaFluor488-conjugated goat anti-rabbit secondary
antibodies, AlexaFluor647-conjugated human transferrin and
AlexaFluor594-conjugated phalloidin were from Molecular
Probes (Invitrogen).
BECLIN-1: P ¼ 0.1769). (D–F) HeLa cells were transfected with 0.5 mg of the GFP-Atg16L1 construct. After 24 h, the cells were treated for 24 h with MAB391,
fixedandanalysedunderfluorescencemicroscope.TheP-values for assessing thepercentageof cells showing≥20GFP-Atg16-positivevesicles aswell as the number
of GFP-Atg16 vesicles/cell were determined by Student’s t-test (E: n ¼ 3; CTRL versus 24 h MAB391, P ¼ 0.00272; F: n ¼ 3; CTRL versus 24 h MAB391, P ¼
0.00496). (G and H) HeLa cells were treated for 24 h with MAB391 and then lysed as detailed in the Methods section. Equal amounts of total protein were immu-
noprecipitated with the anti-ATG16L1 antibody and the amount of interacting clathrin heavy chains assessed by western blot analysis. The graph in (H) shows the
quantitative analysis of endogenous clathrin heavy chain co-immunoprecipitated byAtg16L1. TheP-value of the densitometric analysiswas determined byStudent’s
t-test on three independent experiments (G: n ¼ 3; CTRL versus 24 h MAB391, P ¼ 0.0223). (I and J) HeLa cells were treated for 24 h with 10 mg/ml MAB391 or
LY294002 (10 mM) for the indicated times. The binding and internalization assays for the fluorochrome-conjugated human transferrin were then performed as
described in the Methods section. The amount of internalized ligand was measured by FACS analysis. The graphs report the total amount of internalized transferrin
(Tf) at different time points (as indicated), and normalized to the amount of Tf bound to the cognate receptor at the cell surface at Time 0 (i.e. before the temperature
shift).TheP-values to assess thedifferences in the rate of internalizationof transferrin receptorweredeterminedbyStudent’s t-test onfive independent experiments (I:
n ¼ 5,P-values are shown in the figure; J: n ¼ 5; CTRLversus 8 h LY294002, T10,P ¼ 0.0012; T15,P ¼ 0.0017; CTRL versus 24 h LY294002, T10,P ¼ 0.00022,
T15, P ¼ 0.00031). In all the panels, error bars represent standard deviations.
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Figure 4. IGF-1R depletion reduces Atg16L1 vesicles formation by impairing the actin cytoskeleton dynamics. (A and B) HeLa cells were treated for the indicated
time points with MAB391. Samples were then assayed for evaluating the effect of IGF-1R depletion on the levels of the indicated proteins. The western blots are
representativeof experiments performed in triplicate.Thegraphs in (A)and (B) report the IGF-1Rtoactin, phospho(S473)/totalAKTandphospho/total PKCa relative
levels, respectively. The P-values were determined by two-tailed Student’s t-test (A: n ¼ 3; CTRL versus 24 h MAB391; IGF-1R ∗∗P ¼ 0.00378; P-AKT ∗∗P ¼
0.00586) (B: p-PKCa n ¼ 3; CTRL versus 4 h MAB391 P ¼ 0.43301; CTRL versus 8 h MAB391 P ¼ 0.14323; CTRL versus 2 h MAB391 ∗P ¼ 0.02914).
(C)HeLacellswere treatedornotwithMAB391.After24 h, thecellswerefixed,permeabilized, stainedwithphalloidinandfinallyanalysedbyaconfocalmicroscope.
(D–F) HeLa cells seeded on glass coverslips were transfected with the 0.5 mg of GFP-ATG16 vector and treated or not with 10 mg/ml of the MAB391 neutralizing
antibody. After 24 h, the cells were fixed, permeabilized, stained with phalloidin and finally analysed by a confocal microscope. The P-values for assessing the
number of GFP-ATG16 vesicles, the percentage of cells showing ≥20 GFP-Atg16 vesicles and the actin cytoskeleton derangement were determined by Student’s
t-test (F: n ¼ 3, CTRL versus 24 h MAB391, actin derangement: ∗∗P ¼ 0.00244; percentage of cells with ≥20 ATG16 vesicles/cell: #P ¼ 0.00228; number of
GFP-ATG16 vesicles/cell: §P ¼ 0.00336). In all the panels, error bars represent standard deviations.
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The EGFP-HDQ74 vector was characterized previously (47);
the EGFP-LC3 and EGFP-ATG16L1 were kind gifts from
Yoshimori. The luciferase reporter construct under the
control of the synthetic Forkhead promoter (FOXO-3A luci-
ferase) was a kind gift of Brunet (48). The luciferase vector
containing the human Beclin-1 promoter region has been
described elsewhere (49). The human LC3, Atg16L1, Atg4B
and Ulk-1 promoter vectors were obtained from Yoshida
(50). The Renilla luciferase vector was purchased from
Promega. The chimeric immunoglobulin receptor expression
vector (Fcg-RI-g) has been described previously (51).
Chemicals
The human IGF-1R, Rictor, PKCa and ATG16L1 SMART pool
siRNA reagent (Dharmacon) were used at a final concentration
of 50 nM. The anti-human IGF-1R MAB391 antibody (16) was
used at afinal concentration of 10 mg/ml. The IGF-1R3 analogue
(Sigma) was used at a final concentration of 200 ng/ml. Bafilo-
mycin A1 (Millipore) and rapamycin (Sigma) were used at a
Figure 5.TheRictor/PKCa cascade controls the autophagosome formation by regulating the rate of endocytosis. (A andB) HeLa cells were transfectedwith control,
Rictor, or PKCa siRNA. After 96 h, the cells were lysed and the samples subjected to western blot analysis to evaluate the effect of knockdown on the indicated pro-
teins. The western blots are representative of experiments performed in triplicate. The graph in (B) reports the rictor/actin, and phospho/total PKCa relative levels,
respectively. The P-values were determined by two-tailed Student’s t-test (B: n ¼ 3; CTRL versus Rictor kd; Rictor ∗∗∗P ¼ 0.00089; p-PKC ∗∗P ¼ 0.01225)
(C) HeLa cells seeded on glass coverslips were transfected as indicated in A. After 96, cells were fixed, permeabilized, stained with phalloidin and finally analysed
bya confocalmicroscope. (D)HeLacellswere transfectedwith control, rictor, orPKCa siRNA.After 96 h, the bindingand internalization assaysof thefluorochrome-
conjugated human transferrinwere thenperformed.TheP-values to assess differences in the internalization of transferrin receptorwere determined byStudent’s t-test
on six independent experiments (n ¼ 6, P-values relative to T15 are shown in the figure). (E) The P-values for assessing the number of GFP-Atg16 vesicles, the per-
centage of cells showing≥20GFP-Atg16 vesicles and the actin cytoskeleton derangement were determined by Student’s t-test (n ¼ 3; actin derangement: Rictor kd,
P ¼ 0.0015, PKCa kd, P ¼ 0.0049; percentage of cells with ≥20 ATG16 vesicles: rictor kd,P ¼ 0.0136, PKCa kd,P ¼ 0.0231; number of ATG16 vesicles: Rictor
kd,P ¼ 0.00122, PKCakd,P ¼ 0.00421). (F–H)HeLa cellswere transfected for 96 hwith 50 nMof control, rictor or PKCa siRNA.BafilomycinA1was added to the
cells in the last 4 h before harvesting. The graph shows the LC3-II levels relative to actin panels, error bars represent standard deviations (n ¼ 3; Ctrl versus Rictor kd:
P ¼ 0.0279 and P ¼ 0.0079 in the presence of BafA1; Ctrl versus PKCa kd: P ¼ 0.0145 and P ¼ 0.0005, respectively).
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Figure 6.Chemical inhibitionof IGF-1Rsignalling inhibits autophagy. (A) PPP toxicity assessment.Theorally active IGF-1Rselective inhibitorPPPwasdissolved in
dimethyl sulfoxide (DMSO) and added to normally growing HeLa cells for 24 h at the indicated dosages. Cells were then lysed and analysed by western blot for the
caspase-3cleavage. In theseexperiments, staurosporine (8 hat 1 mM)was includedas apositivecontrol for theactivationof theapoptotic cascade. (BandC)HeLacells
were treated for24 hwith the indicatedconcentrationsof the selective IGF-1RinhibitorPPP.Sampleswere then subjected towesternblot analysis toevaluate the effect
of PPP on the indicated proteins. The western blots are representative of experiments performed in triplicate. The graph in (C) reports the phospho(S473)/total AKT
and phospho/total PKCa relative levels, respectively. TheP-values were determined by a two-tailed Student’s t-test (n ¼ 3; CTRL versus 100 nM PPP, p-AKT ∗P ¼
0.03099; p-PKCa ∗P ¼ 0.04724; CTRLversus 200 nM PPP p-AKT ∗∗∗P ¼ 0.00019; p-PKCa ∗P ¼ 0.02037). (D) HeLa cells were treated for 24 hwith the indicated
concentrationsofPPPandendocytosisof transferrin receptor analysed.TheP-values to assessdifferences in the internalizationof transferrin receptorweredetermined
by Student’s t-test (n ¼ 5, P-values relative for transferrin uptake at T15 in PPP-treated, compared with control cells, are shown in the main figure). (E and F) HeLa
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final concentration of 400 and 200 nM, respectively. Torin
1 (kindly provided by Gray and Sabatini) was dissolved
in dimethyl sulfoxide (DMSO) and used at 200 nM. LY294002
and Latrunculin A (Sigma) were used at final concentrations of
10 and 1 mM, respectively. MG132 (Sigma) was used at 10 mM.
The IGF-1R selective inhibitor picropodophyllotoxin (PPP,
Tocris) was dissolved in DMSO and used at the indicated con-
centrations. Clonidine (Sigma) was dissolved in DMSO and
used at 30 mM. LysoSensor Yellow/Blue DND-160 was from
Molecular Probes (Invitrogen).
Cell culture
HeLa, ATG5+/+ and ATG5–/2 MEF, IGF-1R+/+ and
IGF-1R+/2 MEF cells were grown at 378C in 10% FBS, 2 mM
L-glutamine, pen/strep supplemented Dulbecco’s modified
Eagle’s medium (DMEM). For the IGF-1 forward signalling
experiments, HeLa and MEF cells were serum-deprived for
24 h, and then the IGF-1 R3 was added under the same media
conditions, for different time points ranging from 1 to 24 h, as
detailed in the Results section.
Isolation and culture of mouse primary cortical neurons
Primary cortical neurons were isolated from C57BL/6 mice
embryos at E16.5 (Jackson Laboratories). Briefly, pup brains
were harvested and placed in ice-cold DMEMwhere the menin-
ges were removed and the cerebral cortices were dissected and
incubated in DMEM. After mechanical dissociation using
sterile micropipette tips, dissociated neurons were resuspended
in DMEM and centrifuged. Cell count and viability assay were
performed using the trypan blue exclusion test. Viable cells
were seeded on poly-D-lysine and laminin-coated 6-multiwell
plates (7.5 × 105 cells per well). Cells were cultured in
DMEM supplemented with 2 mM glutamine, 2% B27 supple-
ment and 1%Penicillin-Streptomycin-Fungizone (PSF; Invitro-
gen) at 378C in a humidified incubatorwith 5%CO2and95%O2.
One half of the culturing medium was changed every two days
until treatment. After 7 days of culturing in vitro, differentiated
cortical neuronswereB27-deprived for 24 h and then stimulated
with the IGF-1 R3 analogue as indicated in the relevant figure
legends. For the assessment of autophagy byLC3-II levels, a sat-
urating concentration (400 nM) of bafilomycin A1 was added to
the cells in the last 4 h before harvesting.
Transfection
In all the RNA interference experiments, HeLa cells were trans-
fected 24 h after seeding with a 50 nM final concentration of the
indicated SMARTpool siRNAs using Lipofectamine 2000,
according to the manufacturer’s instructions (Invitrogen).
Cells were then cultured in a full medium for 72–96 h. For the
assessment of autophagy by LC3-II levels, a saturating concen-
tration (400 nM) of bafilomycin A1 was added to the cells in the
last 4 h before harvesting (52). For the EGFP-HD74 aggregation
experiments upon IGF-1R knockdown, HeLa cells were first
transfected as above reported. Forty-four hours after the first
round of transfection, the cells were re-transfected with the fol-
lowing combination: EGFP-HDQ74 plus either control or spe-
cific siRNA (2 mg: 50 nM) and kept in culture for the next 48 h.
To assess the effect of the neutralizing antibody, HeLa cells
were transfected with 2 mg of the EGFP-HD74 for 48 h and
then challenged or not with MAB391 for 24 h. Cells were
finally washed and fixed with 4% paraformaldehyde (Sigma),
mounted in ProLong Antifade (Invitrogen) and observed with
a fluorescence microscope. For the GFP-LC3 dots experiments,
HeLa cells were transfected with 0.5 mg of the EGFP-LC3 for
24 h, challenged or not with MAB391 for the following 24 h
and then fixed, mounted on coverslips and analysed with a fluor-
escence microscope.
IGF-1R knockdown and depletion experiments
In all the RNA interference experiments, cells were transfected
with a 50 nM final concentration of the SMART pool siRNAs
(Dharmacon) using Lipofectamine 2000 (Invitrogen). For the
IGF-1Rdepletion experiments,HeLa cellswere treated at differ-
ent time points with the anti-human IGF-1R MAB391 at a final
concentration of 10 mg/ml.
Transfection experiments for luciferase reporter assays
HeLa cells were seeded in six multiwells and transfected with
0.5 mg of the indicated luciferase reporter vectors plus 0.05 mg
of the renilla luciferase and cultured in a full medium for 24 h.
Cells were then treated or not with the MAB391 neutralizing
antibody for 24 h and finally lysed in reporter lysis buffer
(Promega). Firefly and Renilla luciferase activities were mea-
sured in a luminometer using the Dual-Glo luciferase assay kit
(Promega). The relative luciferase activity (RLU) is defined as
the firefly-to-renilla luciferase activity ratio and normalized for
the protein concentration of each sample. In all experiments,
cells transfectedwith theGFP-ATG16vectorwere treatedor notwith 200 nMofPPP.After 24 h, the cellswerefixed, permeabilized in0.1%TritonX-100, stainedwith
phalloidin and finally analysed by confocal microscopy. The P-values for assessing the number of GFP-ATG16 vesicles, the percentage of cells showing ≥20
GFP-Atg16 vesicles and the actin cytoskeleton derangementwere determined usingStudent’s t-test (n ¼ 3; actin derangement: Ctrl versus PPP,P ¼ 0.0013; percent-
ageof cells showing≥20GFP-Atg16vesicles:Ctrl versusPPP,P ¼ 0.0121;numberofGFP-ATG16vesicles/cell: §P ¼ 0.00629) (G)HeLacellswere treated for24 h
with the indicated concentrations of PPP. Bafilomycin A1 was added to the cells in the last 4 h before harvesting. The graph shows the LC3-II levels relative to actin
(n ¼ 3; 100 nMPPP:P ¼ 0.0081; 200 nMPPP:P ¼ 0.0062, in the absence ofBafA1; 100 nMPPP:P ¼ 0.0031; 200 nMPPP:P ¼ 0.0005, in the presence ofBafA1). In
all the panels, error bars represent standard deviations. (H) HeLa cells were treated as already described in (B). The graph in (I) reports the p62 levels relative to actin.
The P-values were determined by two-tailed Student’s t-test (n ¼ 3; CTRL versus 100 nM PPP; ∗P ¼ 0.0279; ∗∗∗P ¼ 0.00086). (I) PPP impairs clearance of mutant
(A53 T) a-synuclein in stable inducible PC12 cells. The A53 T a-synuclein transgene was induced with doxycycline for 48 h and then switched off (by antibiotic
removal) before the cells were treated with the vehicle alone (DMSO), rapamycin (200 nM) or PPP at the indicated concentrations for a further 24 h. The graph in
(I) reports the A53T-synuclein levels relative to actin. The P-values were determined by a two-tailed Student’s t-test (n ¼ 3; CTRL versus rapamycin ∗∗P ¼
0.0087; CTRL versus 100 nM PPP ∗P ¼ 0.0469; CTRL versus 200 nM PPP ∗P ¼ 0.0122). (J) HeLa cells were transfected with 2 mg of the GFP-HD74 vector for
48 h. In the last 24 h, the cells were treated or not with the indicated concentrations of PPP. The P-value for assessing the EGFP-HDQ74 aggregation was determined
using Student’s t-test (n ¼ 3; CTRL versus 100 nM PPP, ∗∗∗P ¼ 0.00073; CTRL versus 200 nM PPP, ∗∗∗P ¼ 0.00019).
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Figure 7. IGF-1R signalling perturbation reduces autophagy in vivo. (A andB) PPP inhibits autophagic flux in zebrafish larvae. Ammonium chloride (NH4Cl) causes
significant increases in levels of LC3-II in zebrafish larvae, consistent with an ability to block autophagosome/lysosome fusion. Co-treatment with PPP significantly
decreases the levels of LC3-II in the presence of ammoniumchloride. The panel showswestern blots for IGF-1RandLC3-II against actin, used as loading control. The
graphs represent densitometric analyses of three independent experiments (n ¼ 3;P ¼ 0.0349). (C andD)Aggregate countingwas performedusing the heterozygous
larvae fromthe transgenic (rho:EGFP-HTT71Q)cu5 zebrafish line.From3d.p.f. to7d.p.f., transgenicHDzebrafish larvaeweredark-reared inembryomediumaloneor
embryo medium containing either DMSO, 30 mM clonidine or 100 mM PPP. At 7 d.p.f., larvae were anaesthetized and fixed in 4% paraformaldehyde (PFA). Larvae
werewashed, embedded inOCTmediumand frozenondry ice for subsequent cryosectioning.The total numberofGFP-positive aggregateswas countedover 100 mm
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the values are reported as the average and standard deviations of
at least three independent experiments carried out in triplicate.
Statistical analysis was performed using Student’s t-test.
Western blot analysis
Cells were washed and harvested in ice-cold PBS and pellets
were lysed on ice in Laemmli buffer for 30 min, in the presence
of a protease/phosphatase inhibitors mix (Roche). Protein
samples were boiled for 5–7 min at 1008C, separated by
SDS–PAGE, and then subjected to western blot analysis.
Co-immunoprecipitation assays
To analyse the ATG16L1/clathrin heavy-chain interaction,
HeLa cells were lysed on ice for 30 min in Buffer B (10 mM
Tris–HCl, 150 mM NaCl, 1 mM EDTA, pH: 8.0), supplemented
with protease and phosphatase inhibitors mix, in the presence of
1%TritonX-100.Lysatewere thenclearedbycentrifugationand
equal amounts (1.5 mg) of total protein were incubated for 16 h
with the anti-ATG16L1 antibody (1 : 200) on a rotating wheel.
Immunocomplexes were isolated with protein G-sepharose
(GE-Healthcare Amersham), extensively washed, resuspended
and boiled in Laemmli sample buffer, separated by SDS–
PAGE and then subjected to western blot analysis.
Analysis of autophagy
Assessment of autophagic flux by endogenous LC3-II levels or
vesicles, eGFP-LC3 or eGFP-ATG16L1 vesicles and the clear-
ance of exogenous autophagy substrates (A53 T a-synuclein
andGFP-HDQ74 exon 1 huntingtin) were performed as detailed
below.
Quantification of poly-Q74 huntingtin aggregates
formation, LC3-positive and Atg16L1-positive vesicles
Quantification of aggregate formation and LC3 dots were
assessed as already previously described (16,52). Two hundred
EGFP-HDQ74 transfected cells were selected and the number
of cells with aggregates counted using a fluorescence micro-
scope. For quantification of LC3-II dots upon transfection, 200
EGFP-LC3 positive HeLa cells were selected and cells with
20 or more LC3-labelled vesicles were counted. Quantifica-
tion of cells showing GFP-Atg16L1 vesicles was performed as
previously described (9,10). Briefly, the number of
GFP-ATG16L1per transfected cellwas scored, and then the per-
centage of cells showing at ≥20 GFP-ATG16L1-positive
vesicles was also calculated and plotted. The identity of the
slides was unavailable to the observer until all slides had been
studied. The experiments were performed in triplicate and
repeated at least three times. Quantification of endogenous
LC3-II dots was performed as previously described (53). Two
hundred cells for each experimental condition were analysed
by fluorescence microscopy and number of endogenous LC3
dotswere scored in a blinded fashion. TheP-values for assessing
the number of LC3 dots/cell were determined using Student’s
t-test.
Clearance of mutant A53 T a-synuclein
As previously described (54), stable inducible PC12 cell lines
expressingA53Ta-synucleinwere inducedwith 1 mg/ml doxy-
cycline for 48 h. Transgene expression was switched off by re-
moving the antibiotic from the medium and then the cells were
treated for 24 h with the vehicle alone (DMSO), rapamycin
(200 nM) or PPP at the indicated concentrations for a further
24 h. The levels of A53 T transgene were then assessed by
western blot analysis. Experiments were performed in triplicate
and on at least three different occasions and quantified by densi-
tometry normalized to actin.
Ovoalbumin degradation assay
HeLa cells were seeded in six-well plates and transiently trans-
fected with 1 mg of a phagocytosis-competent, chimeric im-
munoglobulin receptor expression vector (Fcg-RI-g) (50) and
cultured in full medium for 24 h. To allow phagocytosis of IgG-
coated beads, HeLa cells were incubated (2 h; 378C) with fluor-
escent beads (Polysciences) covalently conjugated with human
polyclonal IgG and ovalbumin (OVA), thoroughly washed and
then incubated for a further 24 h to permit degradation of inter-
nalized beads in the presence or absence of the anti-human
IGF-1R monoclonal antibody (MAB391). The cells were then
placed at 48C to prevent bead internalization, stained with a
human IgG-specific antibody (Jackson ImmunoResearch) to
mark non-internalized beads and then fixed. Internalized beads
were subsequently recovered by cell disruption (lysis with 1%
Triton X-100 for 30 min followed by homogenization by
passage through a hypodermic needle in the presence of pro-
teases inhibitors) and then incubated with an OVA-specific
FITC-conjugated antibody (Abcam) to detect remaining
bead-associated OVA, which was quantified by flow cytometry
on a FACSCalibur apparatus (Becton Dickinson), as previously
reported (53).
of the central retina, either sideof theoptic nerve.Sectionswereviewedand representative images acquiredusingaGXOpticalLEDfluorescentmicroscope.Numbers
of positive aggregates were scored and mean values were calculated for each treatment group (n ¼ 4 fish/8 eyes; DMSO versus PPP: P ¼ 0.00317). (E and F) PPP
inhibits autophagy and reduces steady-state levels of LC3-II in mice. Mice were subjected to intra-peritoneal injection with either PPP (20 mg/kg/24 h) for 3 days.
Following sacrifice, the liver and muscle were homogenized and samples analysed by western blotting for levels of the indicated proteins. The graphs represent the
mean results of the phospho/total PKCa andLC3-II levels relative to actin from threemice per group (E: liver,n ¼ 3; p-PKCa P ¼ 0.03178, LC3-IIP ¼ 0.02726) (F:
muscle,n ¼ 3; p-PKCa P ¼ 0.02523,LC3-IIP ¼ 0.01843). In all the panels, error bars represent standard deviations. (G) Proposedmodel for the IGF-1R signalling-
dependent modulation of the autophagic pathway. IGF-1R depletion reduces autophagy and has no effect on the canonical mTORC1 complex-mediated signalling
pathway. The reduced amount of autophagosomes present in IGF-1R depleted cells can be, at least in part, explained by a reduced formation of autophagosomal pre-
cursors at the plasmamembrane. In particular, IGF-1Rdepletion inhibitsmTORC2,which in turn reduces the activity of PKCa/b. This perturbs the actin cytoskeleton
dynamics and decreases the rate of clathrin-dependent endocytosis, which negatively impacts autophagosome precursor formation. This has important consequences
for the interpretation of genetic experiments inmammalian systems and for evaluating the potential ofmodulating the signalling through this pathway for therapeutic
purposes.
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Transferrin uptake and internalization assay
In order tomeasure clathrin-dependent endocytosis, internaliza-
tion assays of fluorochrome-conjugated human transferrin (Tf)
were performed using Alexa 647-conjugated Tf (50 mg/ml) at
378C for 0 up to 15 min as previously described (28). Briefly,
HeLa cells were washed once with serum-free medium, trypsi-
nized, collected in Eppendorf tubes, chilled on ice for 15 min
to arrest endocytosis and finally loaded with transferrin to
allow the binding to the tranferrin receptor (20 min on ice).
After binding, the cells were shifted back to 378C and the trans-
ferrin internalization chased at different time points up to
15 min. The amount of internalized ligands was measured by
FACS analysis (FacsCalibur, Becton&Dickinson). The graphs
report the total amount of internalized transferrin at different
timepoints (as indicated), andnormalized to the amount of trans-
ferrin bound to the cognate receptor at the cell surface at Time 0
(i.e. before the temperature shift).
Immunofluorescence, live imaging and confocal microscopy
Cells grown on glass coverslips were fixed in 4% paraformalde-
hyde for 10 min and then permeabilized with either pre-chilled
methanol (5 min at 2208C) or 0.1% Triton X-100 (for the phal-
loidin and GFP-ATG16L1/phalloidin co-staining). 4% goat
serum (Sigma) in 1× PBS was used for blocking (2 h at room
temperature) and for the incubation with the appropriate
primary and secondary antibodies, when necessary. For the
endogenous LC3 and LAMP-1 staining, the cells grown on
glass coverslips were fixed and permeabilized with pre-chilled
methanol (5 min at 2208C). Four percent goat serum (Sigma)
in 1× PBS was used for blocking (2 h at room temperature)
and for the incubation with the appropriate primary and second-
ary antibodies. Coverslips were left in the primary antibody
overnight at 48C. Secondary antibodies were Alexa Fluor-
conjugated antibodies (Molecular Probes, Invitrogen). A Zeiss
Axiovert 200 Mmicroscopewith aLSM510confocal attachment
(63 × NA 1.4 Plan-Apochromat oil-immersion lens LSM510
META,Carl Zeiss) alongwith the LSM510 Image analyser soft-
ware (version 3.2, Carl Zeiss) was used for fluorescent confocal
microscopy involving immunofluorescent staining with Alexa-
Fluor-conjugated secondary antibodies or fluorescently tagged
proteins. All confocal images were taken with a 63×
oil-immersion lens. Microscopy was performed on cells fixed
on coverslips. Coverslips were mounted in Prolong Gold Anti-
fade reagent with 4′,6-diamidino-2-phenylindole (Molecular
Probes, Invitrogen). ImageJ and Photoshop (Adobe) were used
for further analysis and processing of confocal images.
For the pH determination of acidic organelles, LysoSensor
Yellow/Blue DND-160, which produces blue fluorescence in a
neutral environment but shifts to yellow fluorescence in more
acidic compartments (pKa ≈4.2), was used according to the
manufacturer’s instruction (Molecular Probes, Invitrogen).
Briefly, cells were seeded on a MatTek Petri dish (MatTek,
Ashland MA USA) at a density of 1.5 × 105 cells per dish.
The cells were treated or not for 24 h with MAB391, loaded
with the LysoSensor tracer for 1 h at 378C, washed twice with
medium and imaged immediately at 378C. At least 10 pictures
of live cells were taken for each experimental condition. Live
imaging was performed on an Axiovert 200 M microscope
with a LSM 710 confocal attachment using a 63× 1.4 NA Plan
Apochromat oil-immersion lens (Carl Zeiss). In particular, the
cells were excited at 365 nm and images were taken at 450 and
510 nm of emission, respectively. ImageJ and Photoshop
(Adobe) were used for the analysis and processing of confocal
images.
In vivo experiments
Maintenance of zebrafish stocks and collection of embryos
All zebrafish husbandry and experiments were performed in ac-
cordance with UK legislation under a license granted by the
Home Office and with local ethical approval. Zebrafish were
reared under standard conditions on a 14 h light/10 h dark
cycle. Embryos were collected from natural spawnings, staged
according to the established criteria (55) and reared in embryo
medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM
Mg2SO4, 5 mM HEPES).
Determination of the maximum-tolerated concentration
of compounds in larval zebrafish
Compound exposure experiments were performed on wild-type
larvae (TLstrain) from2 to3dayspost-fertilization (d.p.f.).Con-
centration response assays were performed over log intervals,
namely from 1 nM to 100 mM for PPP, in order to determine the
maximum non-toxic concentration (MTC) for subsequent
autophagy assay experiments (n ¼ 30 larvae per concentration).
The MTC for ammonium chloride (NH4Cl) was previously
determined as 100 mM (39,40). Compound exposure experi-
ments were performed in the dark at 28.58C.
Measuring endogenous LC3-II in larval zebrafish
LC3-II assays were performed at the following concentrations:
ammonium chloride at 100 mM, PPP at 100 mM for 24 h. Wild-
type larvae (n ¼ 30 per treatment group) at 2 d.p.f. were
exposed to PPP or embryo medium (untreated control) for 24 h
with or without the addition of ammonium chloride (39).
Larvae were then transferred to chilled tubes, homogenized in
lysis buffer and finally processed for western blotting as
described above.
Aggregate analysis in the transgenic HD zebrafish
Aggregate counting was performed using the heterozygous
larvae from theTg(rho:EGFP-HTT71Q)cu5 zebrafish (41) (here-
after referred to as transgenic HD zebrafish). Embryos from out-
crossed transgenic HD zebrafish were raised in 0.2 mM 1--
phenyl-2-thiourea (PTU) from 1 to 3 d.p.f. in order to inhibit
pigment formation, screened for transgene expression using
EGFP fluorescence then washed twice in the embryo medium
to remove PTU. From 3 to 7 d.p.f., transgenic HD zebrafish
larvae were dark-reared in embryo medium alone or embryo
medium contain containing either DMSO, 30 mM clonidine or
100 mMPPP. Embryomediumand compoundswere replenished
daily. At 7 d.p.f., larvae were anaesthetized by immersion in
0.2 mg/ml 3-amino benzoic acid ethylester (MS222), then
fixed using 4% paraformaldehyde (PFA) in PBS at 48C.
Larvae were washed briefly in PBS, allowed to equilibrate in
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30% sucrose in PBS then embedded in OCT medium (Tissue-
Tek) and frozen on dry ice for subsequent cryosectioning. Sec-
tionswere cut at 10 ?m thickness using aLeicaCM3050 cryostat
and mounted in 80% glycerol in PBS. The total number of
GFP-positive aggregates were counted over 100 mm of the
central retina, either side of the optic nerve using mean values
were calculated (n ¼ 4 fish (8 eyes) for each treatment group).
Sections were viewed and representative images acquired
using a GX Optical LED fluorescent microscope, GXCAM3.3
digital camera and GX Capture software.
Mice experiments
All mice experiments complied with Home Office project and
personal animal licenses. At the start of the study, C57BL/6
mice were aged 35–42 days. Mice were separated by gender
and divided into two groups, each containing three mice. One
group received no treatment (vehicle, DMSO), while the other
group was intraperitoneally injected with PPP (dissolved in
DMSO) at 20 mg/kg/24 h for 3 days (36). Following this, mice
were sacrificed. The liver andmuscle were dissected, frozen im-
mediately after removal and finally homogenized using a
Wheaton glass homogenizer at 48C in lysis buffer (0.25 M Tris,
150 mMNaCl, 1% Triton) in the presence of protease/phosphat-
ase inhibitor cocktail (Roche Scientific). Homogenates were
then centrifuge at 14000 rpm for 30 min at 48C, the supernatants
were collected and analysed by western blot as described above.
Statistical analysis
In all the experiments, we determined the significance levels for
comparisons between groups by a two-tailed Student’s t-test,
repeated measurements or Factorial ANOVA test using STAT-
VIEW v4.53 (Abacus Concepts), where appropriate. Densito-
metric analysis on the immunoblots was performed using
Image J software. Experiments were performed at least three
times in triplicate. In all the main or supplementary figures,
error bars represent standard deviations. The P-values for asses-
sing densitometric analysis on the immunoblots, luciferase
assays, EGFP-HDQ74 aggregation, GFP-LC3 dots formation,
GFP-ATG16L1 vesicles analysis and transferrin uptake assays
were determined using Student’s t-test.
SUPPLEMENTARYMATERIAL
Supplementary Material is available at HMG online.
ACKNOWLEDGEMENTS
We thankKevinMoreau,Maria Jimenez-Sanchez, SovanSarkar
and Shouqing Luo for helpful comments and discussions on the
manuscript.We also thank LucyHepburn,Michelle Stewart and
JimHumphreys for excellent technical assistance.We are grate-
ful for a Wellcome Trust Principal Fellowship (D.C.R.), an
M.R.C. Programme Grant (D.C.R. and S.D.B.), a Wellcome
Trust/MRC strategic grant in dementia and funding from the
NHIR biomedical research unit in dementia at Addenbrooke’s
Hospital. Funding to pay the open access publication charge
will be provided by the Wellcome Trust.
Conflict of Interest statement. None declared.
FUNDING
Funding to pay the Open Access publication charges for this
article was provided by the Wellcome Trust.
REFERENCES
1. Cohen, E., Bieschke, J., Perciavalle, R.M., Kelly, J.W. and Dillin, A. (2006)
Opposing activities protect against age-onset proteotoxicity. Science, 313,
1604–1610.
2. Cohen, E., Paulsson, J.F., Blinder, P., Burstyn-Cohen, T.,Du,D., Estepa,G.,
Adame, A., Pham, H.M., Holzenberger, M., Kelly, J.W. et al. (2009)
Reduced IGF-1 signaling delays age-associated proteotoxicity inmice.Cell,
139, 1157–1169.
3. Freude, S., Hettich, M.M., Schumann, C., Stohr, O., Kock, L., Kohler, C.,
Udelhoven, M., Leeser, U., Muller, M., Kubota, N. et al. (2009) IGF-1
resistance reduces A-beta accumulation and protects against premature
death in a model of Alzheimer’s disease. FASEB J., 23, 3315–3324.
4. Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Geloen, A., Even,
P.C., Cervera, P. and Le Bouc, Y. (2003) IGF-1 receptor regulates lifespan
and resistance to oxidative stress in mice. Nature, 421, 182–187.
5. Mizushima, N. and Komatsu, M. (2011) Autophagy: renovation of cells
and tissues. Cell, 147, 728–741.
6. Ravikumar, B., Sarkar, S., Davies, J.E., Futter, M., Garcia-Arencibia, M.,
Green-Thompson, Z.W., Jimenez-Sanchez, M., Korolchuk, V.I.,
Lichtenberg, M., Luo, S. et al. (2010) Regulation of mammalian autophagy
in physiology and pathophysiology. Physiol. Rev., 90, 1383–1435.
7. Rubinsztein, D.C., Marin˜o, G. and Kroemer, G. (2011) Autophagy and
Aging. Cell, 146, 682–695.
8. Tooze, S.A. and Yoshimori, T. (2010) The origin of the autophagosomal
membrane. Nat Cell Biol., 12, 831–835.
9. Ravikumar, B., Moreau, K., Jahreiss, L., Puri, C. and Rubinsztein, D.C.
(2010) Plasma membrane contributes to the formation of
pre-autophagosomal structures. Nat. Cell Biol., 37, 771–776.
10. Moreau, K., Ravikumar, B., Renna, M., Puri, C. and Rubinsztein, D.C.
(2011) Autophagosome precursor maturation requires homotypic fusion.
Cell, 146, 303–317.
11. Klionsky, D.J., Abdalla, F.C., Abeliovich, H., Abraham, R.T.,
Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P.,
Aguirre-Ghiso, J.A. et al. (2012)Guidelines for the use and interpretation of
assays for monitoring autophagy. Autophagy, 8, 445–544.
12. Jia, G., Cheng, G., Gangahar, D.M. and Agrawal, D.K. (2006) Insulin-like
growth factor-1 and TNF-alpha regulate autophagy through c-jun
N-terminal kinase and Akt pathways in human atherosclerotic vascular
smooth cells. Immunol. Cell Biol., 84, 448–454.
13. Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G.,
Scaravilli, F., Easton, D.F., Duden, R., O’Kane, C.J. and Rubinsztein, D.C.
(2004) Inhibition of mTOR induces autophagy and reduces toxicity of
polyglutamine expansions in fly and mouse models of Huntington disease.
Nat. Genet., 36, 585–595.
14. Korolchuk, V.I., Mansilla, A., Menzies, F.M. and Rubinsztein, D.C. (2009)
Autophagy inhibition compromises degradation of ubiquitin–proteasome
pathway substrates.Mol. Cell, 33, 517–527.
15. Ravikumar, B., Duden, R. and Rubinsztein, D.C. (2002) Aggregate-prone
proteins with polyglutamine and polyalanine expansions are degraded by
autophagy. Hum. Mol. Genet., 11, 1107–1117.
16. Karey, K.P. and Sirbasku, D.A. (1988) Differential Responsiveness of
Human Breast Cancer Cell Lines MCF-7 and T47D to Growth Factors and
17b-Estradiol. Cancer Res., 48, 4083–4092.
17. Korolchuk, V.I., Saiki, S., Lichtenberg, M., Siddiqi, F.H., Roberts, E.A.,
Imarisio, S., Jahreiss, L., Sarkar, S., Futter, M., Menzies, F.M. et al. (2011)
Lysosomal positioning coordinates cellular nutrient responses. Nat. Cell
Biol., 13, 453–460.
18. Williams, T., Forsberg, L.J., Viollet, B. and Brenman, J.E. (2009) Basal
autophagy induction without AMP-activated protein kinase under low
glucose conditions. Autophagy, 5, 1155–1165.
19. Zoncu,R., Efeyan,A. and Sabatini, D.M. (2011)mTOR: fromgrowth signal
integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell. Biol., 12,
21–35.
16 Human Molecular Genetics, 2013
 at Pendlebury Library of M







20. Jacinto, E., Facchinetti, V., Liu, D., Soto, N.,Wei, S., Jung, S.Y., Huang, Q.,
Qin, J. and Su, B. (2006) SIN1/MIP1 maintains rictor-mTOR complex
integrity and regulates Akt phosphorylation and substrate specificity. Cell,
127, 125–137.
21. Zhao, J., Brault, J.J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker,
S.H. and Goldberg, A.L. (2007) FoxO3 coordinately activates protein
degradation by the autophagic/lysosomal and proteasomal pathways in
atrophying muscle cells. Cell Metab., 6, 472–483.
22. Sancak,Y., Bar-Peled, L., Zoncu,R.,Markhard,A.L.,Nada, S. andSabatini,
D.M. (2009) Ragulator-Rag complex targets mTORC1 to the lysosomal
surface and is necessary for its activation by amino acids. Cell, 141,
290–303.
23. Yu,L.,McPhee,C.K.,Zheng,L.,Mardones,G.A.,Rong,Y., Peng, J.,Mi,N.,
Zhao, Y., Liu, Z., Wan, F. et al. (2010) Termination of autophagy and
reformation of lysosomes regulated by mTOR. Nature, 465, 942–946.
24. Hanada, T., Noda, N.N., Satomi, Y., Ichimura, Y., Fujioka, Y., Takao, T.,
Inagaki, F. and Ohsumi, Y. (2007) The Atg12-Atg5 conjugate has a novel
E3-like activity for protein lipidation in autophagy. J. Biol. Chem., 282,
37298–37302.
25. Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N.,
Packer, M., Schneider, M.D. and Levine, B. (2005) Bcl-2 antiapoptotic
proteins inhibit Beclin 1-dependent autophagy. Cell, 122, 927–939.
26. Tasdemir, E., Maiuri, M.C., Galluzzi, L., Vitale, I., Djavaheri-Mergny, M.,
D’Amelio, M., Criollo, A., Morselli, E., Zhu, C., Harper, F. et al. (2008)
Regulation of autophagy by cytoplasmic p53.Nat. Cell Biol., 10, 676–687.
27. Doherty, G.J. and McMahon, H.T. (2009) Mechanisms of endocytosis.
Annu. Rev. Biochem., 78, 857–902.
28. Tosoni,D., Puri,C.,Confalonieri, S., Salcini,A.E.,DeCamilli, P., Tacchetti,
C. and Di Fiore, P.P. (2005) TPP specifically regulates the internalization of
the transferrin receptor. Cell, 123, 875–888.
29. Larsson, C. (2006) Protein kinase C and the regulation of the actin
cytoskeleton. Cell Signal., 18, 276–284.
30. Oh, W.J. and Jacinto, E. (2011) mTOR complex 2 signaling and functions.
Cell Cycle, 10, 2305–2316.
31. Sarbassov, D.D., Ali, S.M., Kim, D.H., Guertin, D.A., Latek, R.R.,
Erdjument-Bromage, H., Tempst, P. and Sabatini, D.M. (2004) Rictor, a
novel binding partner of mTOR, defines a rapamycin-insensitive and
raptor-independent pathway that regulates the cytoskeleton.Curr. Biol., 14,
1296–1302.
32. Mooren, O.L., Galletta, B.J. and Cooper, J.A. (2012) Roles for actin
assembly in endocytosis. Annu. Rev. Biochem., 81, 661–686.
33. Aguileira, M.O., Beron, W. and Colombo, M.I. (2012) The actin
cytoskeleton participates in the early events of autophagosome formation
upon starvation-induced autophagy. Autophagy, 8, 1590–1603.
34. Thoreen, C.C., Kang, S.A., Chang, J.W., Liu, Q., Zhang, J., Gao, Y.,
Reichling, L.J., Sim, T., Sabatini, D.M. and Gray, N.S. (2009) An
ATP-competitive mammalian target of rapamycin inhibitor reveals
rapamycin-resistant functions of mTORC1. J. Biol. Chem., 284,
8023–8032.
35. Girnita, A., Girnita, L., Del Prete, F., Bartolazzi, A., Larsson, O. and
Axelson, M. (2004) Cyclolignans as inhibitors of the insulin-like growth
factor-1 receptor and malignant cell growth. Cancer Res., 64, 236–242.
36. Economou, M.A., Wu, J., Vasilcanu, D., Rosengren, L., All-Ericsson, C.,
vander Ploeg, I.,Menu,E.,Girnita, L.,Axelson,M., Larsson,O. et al. (2008)
Inhibition of VEGF secretion and experimental choroidal
neovascularization by picropodophyllin (PPP), an inhibitor of the
insulin-like growth factor-1 receptor. Invest. Ophthalmol. Vis. Sci.,
49, 2620–2626.
37. Lee, H.V., Smith, L., Pettit, G.R., Vinitsky, A. and Smith, J.B. (1996)
Ubiquitinationof proteinkinaseC-alphaanddegradationby theproteasome.
J. Biol. Chem., 271, 20973–20976.
38. Lu, Z., Liu, D., Hornia, A., Devonish, W., Pagano, M. and Foster, D.A.
(1998) Activation of Protein kinase C triggers its ubiquitination and
degradation.Mol. Cell. Biol., 18, 839–845.
39. Underwood,B.R., Imarisio,S., Fleming,A.,Rose,C.,Krishna,G.,Heard,P.,
Quick,M., Korolchuk, V.I., Renna,M., Sarkar, S. et al. (2010)Antioxidants
can inhibit basal autophagy and enhance neurodegeneration in models of
polyglutamine disease. Hum. Mol. Genet., 19, 3413–3429.
40. Sarkar, S., Korolchukm, V.I., Renna, M., Imarisio, S., Fleming, A.,
Williams, A., Garcia-Arencibia, M., Rose, C., Luo, S., Underwood, B.R.
et al. (2011) Complex inhibitory effects of nitric oxide on autophagy.Mol.
Cell., 43, 19–32.
41. Williams, A., Sarkar, S., Cuddon, P., Ttofi, E.K., Saiki, S., Siddiqi, F.H.,
Jahreiss, L., Fleming, A., Pask, D., Goldsmith, P. et al. (2008) Novel targets
forHuntington’s disease in anmTOR-independent autophagypathway.Nat.
Chem. Biol., 4, 295–305.
42. Yamamoto, A., Cremona, M.L. and Rothman, J.E. (2006)
Autophagy-mediated clearance of huntingtin aggregates triggered by the
insulin-signaling pathway. J. Cell Biol., 172, 719–731.
43. Rubinsztein, D.C., Codogno, P. and Levine, B. (2012) Autophagy
modulation as a potential therapeutic target for diverse diseases. Nat. Rev.
Drug Discov., 11, 709–730.
44. Bokov, A.F., Garg, N., Ikeno, Y., Thakur, S., Musi, N., DeFronzo, R.A.,
Zhang, N., Erickson, R.C., Gelfond, J., Hubbard, G.B. et al. (2011) Does
reduced IGF-1R signaling in Igf1r+/- mice alter aging?. PLoS One, 6,
e26891; .
45. Wang, R.C., Wei, Y., An, Z., Zou, Z., Xiao, G., Bhagat, G., White, M.,
Reichelt, J. andLevine,B. (2012)Akt-mediated regulationof autophagyand
tumorigenesis through Beclin 1 phosphorylation. Science, 338, 956–959.
46. Choi, A.M., Ryter, S.W. and Levine, B. (2013) Autophagy in human health
and disease. N. Engl. J. Med., 368, 651–662.
47. Narain,Y.,Wyttenbach,A., Rankin, J., Furlong, R.A. andRubinsztein, D.C.
(1999)Amolecular investigationof true dominance inHuntington’sdisease.
J. Med. Genet., 36, 739–746.
48. Brunet, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, P., Hum, L.S.,
Anderson, M.J., Arden, K.C., Blenis, J. and Greenberg, M.E. (1999)
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell, 96, 857–868.
49. Tang,H., Da, L.,Mao,Y., Li, Y., Li, D., Xu, Z., Li, F.,Wang,Y., Tiollais, P.,
Li, T. and Zhao, M. (2010) Hepatitis B virus X protein sensitizes cells to
starvation-induced autophagy via up-regulation of beclin 1 expression.
Hepatology, 49, 60–71.
50. Kusama,Y., Sato,K.,Kimura,N.,Mitamura, J.,Ohdaira,H. andYoshida,K.
(2009) Comprehensive analysis of expression pattern and promoter
regulation of human autophagy-related genes. Apoptosis, 14, 1165–1175.
51. Hutchinson, M.J., Harrison, P.T., Floto, R.A. and Allen, J.M. (1995) Fc
gamma receptor-mediated phagocytosis requires tyrosine kinase activity
and is ligand independent. Eur. J. Immunol., 25, 481–487.
52. Sarkar, S., Krishna,G., Imarisio, S., Saiki, S., O’Kane, C.J. andRubinsztein,
D.C. (2008) A rationale mechanism for combination treatment of
Huntington’s disease using lithium and rapamycin. Hum. Mol. Genet.,
17, 170–178.
53. Renna, M., Schaffner, C., Winslow, A.R., Menzies, F.M., Peden, A.A.,
Floto, R.A. and Rubinsztein, D.C. (2011) Autophagic substrate clearance
requires activity of the syntaxin-5 SNARE complex. J. Cell Sci., 124,
469–482.
54. Webb, J.L., Ravikumar, B., Atkins, J., Skepper, J.N. and Rubinsztein, D.C.
(2003) Alpha-synuclein is degraded by both autophagy and the proteasome.
J. Biol. Chem., 278, 25009–25013.
55. Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B. and Schilling,
T.F. (1995) Stages of embryonic development of the zebrafish. Dev. Dyn.,
203, 253–310.
Human Molecular Genetics, 2013 17
 at Pendlebury Library of M
usic on July 26, 2013
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
